Medical technology firm Medtronic is exploring opportunities to replicate its successful partnership model with the Punjab government for stroke care in additional states, according to a senior executive.
The primary objective is to manage stroke incidents effectively within 24 hours of occurrence, explained Mandeep Singh Kumar, Managing Director and Vice President of Medtronic India. The collaboration with the Punjab government and CMC Ludhiana aims to enhance stroke care by linking smaller medical centers to a centralized hub. Additionally, Medtronic has joined forces with Qure.ai to implement artificial intelligence for screening patients’ risks and ensuring they receive the correct treatment pathway, as Kumar shared with BusinessLine.
Currently, Medtronic has established partnerships in five states—Punjab, Uttar Pradesh, Haryana, Gujarat, and Kerala—though the Punjab initiative is the only one involving government collaboration. The company aims to extend this model to more states and is also exploring similar partnership frameworks for other medical conditions.
In regard to managing varicose veins, Medtronic is focusing on creating “vein clinics” to provide necessary treatment for this condition, which can pose health risks if ignored. A representative from the company highlighted that Medtronic supplies varicose vein treatment solutions along with training and education for healthcare professionals, as well as initiatives aimed at raising patient awareness to improve health outcomes. Currently, three vein clinics have been established in collaboration with various partners, including a clinic in Bengaluru at Aveksha Hospital with the Swizton Group, the Vein and Foot Clinic in Chennai, and the Hyderabad Vascular Center.
Regarding stroke care advancements, Kumar mentioned the PRAAN registry—a collaborative initiative sponsored by industry stakeholders that collects real-world data on mechanical thrombectomy outcomes for patients with acute ischemic stroke resulting from large vessel occlusion. The registry has enrolled 200 patients over a two-year period across 14 centers, providing evidence that mechanical thrombectomy is a safe, effective, and cost-efficient treatment option for acute ischemic stroke in India.
In 2020, the Ireland-based company announced a significant investment of ₹1,200 crore over five years to expand its research and development center in Hyderabad and create approximately 1,000 jobs. This investment represents one of the largest commitments by the company outside the United States, reaffirming its dedication to software design and technological innovation in the healthcare sector.
